Structure of MlaFB uncovers novel mechanisms of ABC transporter regulation
- New York University School of Medicine, United States
Abstract
ABC transporters facilitate the movement of diverse molecules across cellular membranes, but how their activity is regulated post-translationally is not well understood. Here we report the crystal structure of MlaFB from E. coli, the cytoplasmic portion of the larger MlaFEDB ABC transporter complex, which drives phospholipid trafficking across the bacterial envelope to maintain outer membrane integrity. MlaB, a STAS domain protein, binds the ABC nucleotide binding domain, MlaF, and is required for its stability. Our structure also implicates a unique C-terminal tail of MlaF in self-dimerization. Both the C-terminal tail of MlaF and the interaction with MlaB are required for the proper assembly of the MlaFEDB complex and its function in cells. This work leads to a new model for how an important bacterial lipid transporter may be regulated by small proteins, and raises the possibility that similar regulatory mechanisms may exist more broadly across the ABC transporter family.
Data availability
The structure factors and coordinates for crystal structures were deposited in the Protein Data Bank with accession codes 6XGY (dimeric MlaFB with ADP+Mg) and 6XGZ (monomeric MlaFB in apo state). Plasmids generated in this study have been deposited in Addgene. All data generated or analysed during this study are included in the manuscript and supporting files.
Article and author information
Author details
Funding
American Heart Association (20POST35210202)
- Georgia L Isom
National Institutes of Health (T32 GM088118)
- Mark R MacRae
National Institutes of Health (R35GM128777)
- Damian C Ekiert
Damon Runyon Cancer Research Foundation (DFS‐20‐16)
- Gira Bhabha
National Institutes of Health (R00GM112982)
- Gira Bhabha
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- László Csanády, Semmelweis University, Hungary
Version history
- Received: June 15, 2020
- Accepted: June 24, 2020
- Accepted Manuscript published: June 30, 2020 (version 1)
- Version of Record published: July 17, 2020 (version 2)
Copyright
© 2020, Kolich et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,907
- views
-
- 309
- downloads
-
- 30
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Structure of MlaFB uncovers novel mechanisms of ABC transporter regulation
eLife 9:e60030.
https://doi.org/10.7554/eLife.60030
Further reading
-
- Cell Biology
- Structural Biology and Molecular Biophysics
Advanced cryo-EM approaches reveal surprising insights into the molecular structure that allows nascent proteins to be inserted into the membrane of the endoplasmic reticulum.
-
- Developmental Biology
- Structural Biology and Molecular Biophysics
The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, Brachydactyly B and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.
